These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28328626)

  • 21. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
    Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
    J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis.
    Navaneethan U; Venkatesh PG; Bennett AE; Patel V; Hammel J; Kiran RP; McCullough AJ; Shen B
    J Crohns Colitis; 2012 Jun; 6(5):536-42. PubMed ID: 22398056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: budesonide MMX for ulcerative colitis?
    Prantera C
    Aliment Pharmacol Ther; 2014 Jun; 39(12):1435. PubMed ID: 24849158
    [No Abstract]   [Full Text] [Related]  

  • 25. Budesonide (Uceris) for ulcerative colitis.
    Med Lett Drugs Ther; 2013 Mar; 55(1412):23-4. PubMed ID: 23507873
    [No Abstract]   [Full Text] [Related]  

  • 26. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial.
    Gross V; Bunganic I; Belousova EA; Mikhailova TL; Kupcinskas L; Kiudelis G; Tulassay Z; Gabalec L; Dorofeyev AE; Derova J; Dilger K; Greinwald R; Mueller R;
    J Crohns Colitis; 2011 Apr; 5(2):129-38. PubMed ID: 21453882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis.
    Criscuoli V; Sinagra E; Cottone M
    Gastroenterology; 2013 Mar; 144(3):e23. PubMed ID: 23352592
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ulcerative colitis. Complementary therapies].
    Matthes H; Moser G; Jantschek G
    Z Gastroenterol; 2004 Sep; 42(9):1031-2. PubMed ID: 15455282
    [No Abstract]   [Full Text] [Related]  

  • 29. Probiotics in inflammatory bowel disease: is it fair to lump them into a one size that fits all?
    Mardini HE; Grigorian A
    Inflamm Bowel Dis; 2014 Jun; 20(6):e14. PubMed ID: 24788040
    [No Abstract]   [Full Text] [Related]  

  • 30. Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.
    Kelly OB; Rosenberg M; Tyler AD; Stempak JM; Steinhart AH; Cohen Z; Greenberg GR; Silverberg MS
    J Crohns Colitis; 2016 Apr; 10(4):410-7. PubMed ID: 26721938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central serous retinopathy associated with topical oral corticosteroid use: a case report.
    O'Brien P; Young RC; Ghafoori SD; Harper CA; Wong RW
    J Med Case Rep; 2019 Jul; 13(1):201. PubMed ID: 31262360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel extended release budesonide formulation for treatment of ulcerative colitis.
    Farkas K; Molnár T
    Expert Opin Pharmacother; 2014 Jan; 15(1):131-7. PubMed ID: 24219763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reply to Mardini and Grigorian.
    Shen J; Mao AP
    Inflamm Bowel Dis; 2014 Jun; 20(6):e14-5. PubMed ID: 24788041
    [No Abstract]   [Full Text] [Related]  

  • 34. Incorrect citation and analysis in meta-analysis.
    Wildt S; Rumessen JJ; Nordgaard-Lassen I
    Inflamm Bowel Dis; 2014 Dec; 20(12):E25. PubMed ID: 25397895
    [No Abstract]   [Full Text] [Related]  

  • 35. Alicaforsen in the treatment of pouchitis.
    Greuter T; Rogler G
    Immunotherapy; 2017 Nov; 9(14):1143-1152. PubMed ID: 29067882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serous central chorioretinopathy and tadalafil: a case report].
    Nadeau S; Nguyen F; Guigou S
    J Fr Ophtalmol; 2012 Feb; 35(2):121.e1-5. PubMed ID: 21680058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between fecal hydrogen sulfide production and pouchitis.
    Ohge H; Furne JK; Springfield J; Rothenberger DA; Madoff RD; Levitt MD
    Dis Colon Rectum; 2005 Mar; 48(3):469-75. PubMed ID: 15747080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis.
    Lichtenstein GR; Travis S; Danese S; D'Haens G; Moro L; Jones R; Huang M; Ballard ED; Bagin R; Hardiman Y; Collazo R; Sandborn WJ
    J Crohns Colitis; 2015 Sep; 9(9):738-46. PubMed ID: 26094251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent Central Serous Chorioretinopathy Under Combined Vemurafenib and Cobimetinib Treatment.
    Kouros P; Gerding H
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):488-9. PubMed ID: 27116515
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
    Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
    J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.